List of Tables
Table 1. Global End Stage Renal Disease Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global End Stage Renal Disease Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global End Stage Renal Disease Drug Market Competitive Situation by Manufacturers in 2023
Table 4. Global End Stage Renal Disease Drug Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global End Stage Renal Disease Drug Sales Market Share by Manufacturers (2019-2024)
Table 6. Global End Stage Renal Disease Drug Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global End Stage Renal Disease Drug Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market End Stage Renal Disease Drug Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of End Stage Renal Disease Drug, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of End Stage Renal Disease Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of End Stage Renal Disease Drug, Product Type & Application
Table 12. Global Key Manufacturers of End Stage Renal Disease Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global End Stage Renal Disease Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in End Stage Renal Disease Drug as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global End Stage Renal Disease Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global End Stage Renal Disease Drug Sales by Region (2019-2024) & (K Units)
Table 18. Global End Stage Renal Disease Drug Sales Market Share by Region (2019-2024)
Table 19. Global End Stage Renal Disease Drug Sales by Region (2025-2030) & (K Units)
Table 20. Global End Stage Renal Disease Drug Sales Market Share by Region (2025-2030)
Table 21. Global End Stage Renal Disease Drug Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global End Stage Renal Disease Drug Revenue Market Share by Region (2019-2024)
Table 23. Global End Stage Renal Disease Drug Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global End Stage Renal Disease Drug Revenue Market Share by Region (2025-2030)
Table 25. North America End Stage Renal Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America End Stage Renal Disease Drug Sales by Country (2019-2024) & (K Units)
Table 27. North America End Stage Renal Disease Drug Sales by Country (2025-2030) & (K Units)
Table 28. North America End Stage Renal Disease Drug Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America End Stage Renal Disease Drug Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe End Stage Renal Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe End Stage Renal Disease Drug Sales by Country (2019-2024) & (K Units)
Table 32. Europe End Stage Renal Disease Drug Sales by Country (2025-2030) & (K Units)
Table 33. Europe End Stage Renal Disease Drug Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe End Stage Renal Disease Drug Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific End Stage Renal Disease Drug Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific End Stage Renal Disease Drug Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific End Stage Renal Disease Drug Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific End Stage Renal Disease Drug Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific End Stage Renal Disease Drug Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America End Stage Renal Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America End Stage Renal Disease Drug Sales by Country (2019-2024) & (K Units)
Table 42. Latin America End Stage Renal Disease Drug Sales by Country (2025-2030) & (K Units)
Table 43. Latin America End Stage Renal Disease Drug Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America End Stage Renal Disease Drug Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa End Stage Renal Disease Drug Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa End Stage Renal Disease Drug Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa End Stage Renal Disease Drug Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa End Stage Renal Disease Drug Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa End Stage Renal Disease Drug Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global End Stage Renal Disease Drug Sales (K Units) by Type (2019-2024)
Table 51. Global End Stage Renal Disease Drug Sales (K Units) by Type (2025-2030)
Table 52. Global End Stage Renal Disease Drug Sales Market Share by Type (2019-2024)
Table 53. Global End Stage Renal Disease Drug Sales Market Share by Type (2025-2030)
Table 54. Global End Stage Renal Disease Drug Revenue (US$ Million) by Type (2019-2024)
Table 55. Global End Stage Renal Disease Drug Revenue (US$ Million) by Type (2025-2030)
Table 56. Global End Stage Renal Disease Drug Revenue Market Share by Type (2019-2024)
Table 57. Global End Stage Renal Disease Drug Revenue Market Share by Type (2025-2030)
Table 58. Global End Stage Renal Disease Drug Price (US$/Unit) by Type (2019-2024)
Table 59. Global End Stage Renal Disease Drug Price (US$/Unit) by Type (2025-2030)
Table 60. Global End Stage Renal Disease Drug Sales (K Units) by Application (2019-2024)
Table 61. Global End Stage Renal Disease Drug Sales (K Units) by Application (2025-2030)
Table 62. Global End Stage Renal Disease Drug Sales Market Share by Application (2019-2024)
Table 63. Global End Stage Renal Disease Drug Sales Market Share by Application (2025-2030)
Table 64. Global End Stage Renal Disease Drug Revenue (US$ Million) by Application (2019-2024)
Table 65. Global End Stage Renal Disease Drug Revenue (US$ Million) by Application (2025-2030)
Table 66. Global End Stage Renal Disease Drug Revenue Market Share by Application (2019-2024)
Table 67. Global End Stage Renal Disease Drug Revenue Market Share by Application (2025-2030)
Table 68. Global End Stage Renal Disease Drug Price (US$/Unit) by Application (2019-2024)
Table 69. Global End Stage Renal Disease Drug Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Inc Corporation Information
Table 71. Pfizer Inc Description and Business Overview
Table 72. Pfizer Inc End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Inc End Stage Renal Disease Drug Product
Table 74. Pfizer Inc Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. AstraZeneca End Stage Renal Disease Drug Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Bristol-Myers Squibb Company Corporation Information
Table 81. Bristol-Myers Squibb Company Description and Business Overview
Table 82. Bristol-Myers Squibb Company End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Bristol-Myers Squibb Company End Stage Renal Disease Drug Product
Table 84. Bristol-Myers Squibb Company Recent Developments/Updates
Table 85. Dr. Reddy's Laboratories Ltd Corporation Information
Table 86. Dr. Reddy's Laboratories Ltd Description and Business Overview
Table 87. Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Dr. Reddy's Laboratories Ltd End Stage Renal Disease Drug Product
Table 89. Dr. Reddy's Laboratories Ltd Recent Developments/Updates
Table 90. Endo International plc Corporation Information
Table 91. Endo International plc Description and Business Overview
Table 92. Endo International plc End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Endo International plc End Stage Renal Disease Drug Product
Table 94. Endo International plc Recent Developments/Updates
Table 95. Teva Pharmaceutical Industries Ltd Corporation Information
Table 96. Teva Pharmaceutical Industries Ltd Description and Business Overview
Table 97. Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Teva Pharmaceutical Industries Ltd End Stage Renal Disease Drug Product
Table 99. Teva Pharmaceutical Industries Ltd Recent Developments/Updates
Table 100. Sun Pharmaceutical Industries Ltd Corporation Information
Table 101. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 102. Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Sun Pharmaceutical Industries Ltd End Stage Renal Disease Drug Product
Table 104. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 105. Mylan NV Corporation Information
Table 106. Mylan NV Description and Business Overview
Table 107. Mylan NV End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Mylan NV End Stage Renal Disease Drug Product
Table 109. Mylan NV Recent Developments/Updates
Table 110. Novartis AG Corporation Information
Table 111. Novartis AG Description and Business Overview
Table 112. Novartis AG End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Novartis AG End Stage Renal Disease Drug Product
Table 114. Novartis AG Recent Developments/Updates
Table 115. Lupin Corporation Information
Table 116. Lupin Description and Business Overview
Table 117. Lupin End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Lupin End Stage Renal Disease Drug Product
Table 119. Lupin Recent Developments/Updates
Table 120. Cipla Inc Corporation Information
Table 121. Cipla Inc Description and Business Overview
Table 122. Cipla Inc End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Cipla Inc End Stage Renal Disease Drug Product
Table 124. Cipla Inc Recent Developments/Updates
Table 125. Aurobindo Pharma Corporation Information
Table 126. Aurobindo Pharma Description and Business Overview
Table 127. Aurobindo Pharma End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Aurobindo Pharma End Stage Renal Disease Drug Product
Table 129. Aurobindo Pharma Recent Developments/Updates
Table 130. Fresenius SE & Co. KGaA Corporation Information
Table 131. Fresenius SE & Co. KGaA Description and Business Overview
Table 132. Fresenius SE & Co. KGaA End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Fresenius SE & Co. KGaA End Stage Renal Disease Drug Product
Table 134. Fresenius SE & Co. KGaA Recent Developments/Updates
Table 135. Sanofi Corporation Information
Table 136. Sanofi Description and Business Overview
Table 137. Sanofi End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Sanofi End Stage Renal Disease Drug Product
Table 139. Sanofi Recent Developments/Updates
Table 140. Takeda Pharmaceutical Company Limited Corporation Information
Table 141. Takeda Pharmaceutical Company Limited Description and Business Overview
Table 142. Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Takeda Pharmaceutical Company Limited End Stage Renal Disease Drug Product
Table 144. Takeda Pharmaceutical Company Limited Recent Developments/Updates
Table 145. F. Hoffmann-La Roche Ltd Corporation Information
Table 146. F. Hoffmann-La Roche Ltd Description and Business Overview
Table 147. F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. F. Hoffmann-La Roche Ltd End Stage Renal Disease Drug Product
Table 149. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 150. Kissei Pharmaceutical Co., Ltd Corporation Information
Table 151. Kissei Pharmaceutical Co., Ltd Description and Business Overview
Table 152. Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Kissei Pharmaceutical Co., Ltd End Stage Renal Disease Drug Product
Table 154. Kissei Pharmaceutical Co., Ltd Recent Developments/Updates
Table 155. Abbott Corporation Information
Table 156. Abbott Description and Business Overview
Table 157. Abbott End Stage Renal Disease Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Abbott End Stage Renal Disease Drug Product
Table 159. Abbott Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. End Stage Renal Disease Drug Distributors List
Table 163. End Stage Renal Disease Drug Customers List
Table 164. End Stage Renal Disease Drug Market Trends
Table 165. End Stage Renal Disease Drug Market Drivers
Table 166. End Stage Renal Disease Drug Market Challenges
Table 167. End Stage Renal Disease Drug Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of End Stage Renal Disease Drug
Figure 2. Global End Stage Renal Disease Drug Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global End Stage Renal Disease Drug Market Share by Type in 2023 & 2030
Figure 4. Calcimimetics Product Picture
Figure 5. Vitamin D Product Picture
Figure 6. Sterols Product Picture
Figure 7. Potassium Binders Product Picture
Figure 8. Calcium-Based Phosphate Binders Product Picture
Figure 9. Other Product Picture
Figure 10. Global End Stage Renal Disease Drug Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 11. Global End Stage Renal Disease Drug Market Share by Application in 2023 & 2030
Figure 12. End Stage Renal Disease Induced Hyperparathyroidism
Figure 13. End Stage Renal Disease Induced Hyperphosphatemia
Figure 14. End Stage Renal Disease Induced Hyperkalaemia
Figure 15. Global End Stage Renal Disease Drug Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global End Stage Renal Disease Drug Market Size (2019-2030) & (US$ Million)
Figure 17. Global End Stage Renal Disease Drug Sales (2019-2030) & (K Units)
Figure 18. Global End Stage Renal Disease Drug Average Price (US$/Unit) & (2019-2030)
Figure 19. End Stage Renal Disease Drug Report Years Considered
Figure 20. End Stage Renal Disease Drug Sales Share by Manufacturers in 2023
Figure 21. Global End Stage Renal Disease Drug Revenue Share by Manufacturers in 2023
Figure 22. The Global 5 and 10 Largest End Stage Renal Disease Drug Players: Market Share by Revenue in 2023
Figure 23. End Stage Renal Disease Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 24. Global End Stage Renal Disease Drug Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 25. North America End Stage Renal Disease Drug Sales Market Share by Country (2019-2030)
Figure 26. North America End Stage Renal Disease Drug Revenue Market Share by Country (2019-2030)
Figure 27. United States End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Canada End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Europe End Stage Renal Disease Drug Sales Market Share by Country (2019-2030)
Figure 30. Europe End Stage Renal Disease Drug Revenue Market Share by Country (2019-2030)
Figure 31. Germany End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. France End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. U.K. End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Italy End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Russia End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Asia Pacific End Stage Renal Disease Drug Sales Market Share by Region (2019-2030)
Figure 37. Asia Pacific End Stage Renal Disease Drug Revenue Market Share by Region (2019-2030)
Figure 38. China End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Japan End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. South Korea End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. India End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Australia End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. China Taiwan End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Southeast Asia End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Latin America End Stage Renal Disease Drug Sales Market Share by Country (2019-2030)
Figure 46. Latin America End Stage Renal Disease Drug Revenue Market Share by Country (2019-2030)
Figure 47. Mexico End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Brazil End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Argentina End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa End Stage Renal Disease Drug Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa End Stage Renal Disease Drug Revenue Market Share by Country (2019-2030)
Figure 52. Turkey End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE End Stage Renal Disease Drug Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of End Stage Renal Disease Drug by Type (2019-2030)
Figure 56. Global Revenue Market Share of End Stage Renal Disease Drug by Type (2019-2030)
Figure 57. Global End Stage Renal Disease Drug Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of End Stage Renal Disease Drug by Application (2019-2030)
Figure 59. Global Revenue Market Share of End Stage Renal Disease Drug by Application (2019-2030)
Figure 60. Global End Stage Renal Disease Drug Price (US$/Unit) by Application (2019-2030)
Figure 61. End Stage Renal Disease Drug Value Chain
Figure 62. End Stage Renal Disease Drug Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
